J-STAR Research has recently established significant impurity isolation and structural elucidation capabilities. The R&D team is comprised of experts in identifying and characterizing low levels (e.g. 0.1%) of impurities in chemical intermediates and APIs. This is done by impurity enrichment …
South Plainfield, NJ., March 12, 2020 — J-STAR Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://jstar-bkp.sytech.site. The new site …
March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to carry out all-round strategic cooperation on the …
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary …
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary …
